A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
Year: 2024
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1111/head.14835
Institution: University of California, San Francisco
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W4402988663
